title: The efficacy of terazosin for treating benign prostatic hyperplasia: a multicentre clinical trial.
authors.affiliation: Clinic of Urology, Institute of Surgery of the Military Medical Academy, Zeromskiego st 113, 90-549 Lodz, Poland.
authors.forename: E
authors.initials: E
authors.lastname: Miekos
authors.forename: Z
authors.initials: Z
authors.lastname: Trzepizur
authors.forename: W
authors.initials: W
authors.lastname: Rózanski
authors.forename: R
authors.initials: R
authors.lastname: Boniecki
authors.forename: J
authors.initials: J
authors.lastname: Kusnierz
authors.forename: Z
authors.initials: Z
authors.lastname: Jablonowski
authors.forename: C
authors.initials: C
authors.lastname: Zydek
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D008875:Middle Aged; D011224:Prazosin / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D016896:Treatment Outcome; D016055:Urinary Retention / Q000188:drug therapy / Q000209:etiology
chemical_list: D000317:Adrenergic alpha-Antagonists; C041226:Terazosin; D011224:Prazosin